Zhou C, Wang Z, Sun Y, Cao L, et al. Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial. Lancet Oncol 2022 Jan 14. pii: S1470-2045(21)00650.
PMID: 35038432